David Ting

Scientific Co-Founder at PanTher Therapeutics

Dr. Ting is a translational pancreatic cancer researcher and practicing board certified oncologist at the Massachusetts General Hospital (MGH) Cancer Center. He obtained BS degrees in both biology and chemical engineering from MIT and completed his MD at Harvard Medical School. He performed biomedical research under Dr. Robert Langer working on DNA vaccine delivery systems and then a Howard Hughes Medical Fellowship with Dr. George Daley on stem cell research.

David is now an Assistant Professor at the MGH Cancer Center and Harvard Medical School directing a translational research laboratory focused on pancreatic cancer.

Links